Recent studies found elevated levels of RANK ligand in combination with MIP1-α or IL-6 in high frequencies of patients with multiple myeloma, and experimental results suggest that the relationship between these transcription factors are important to osteoclast proliferation [69]. Here, IL6 is linked to plasma cell myeloma.